ASX - Delayed Quote
AUD
Biome Australia Limited (BIO.AX)
0.3500
-0.0100
(-2.78%)
At close: 3:33:04 PM GMT+11
Key Executives
Amounts are as of December 31, 2026 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Blair William Brabin Vega Norfolk
|
MD, CEO & Director | 679k | -- | 1985 |
|
Ms. Lauren Dwyer
|
Chief Financial Officer | 329.2k | -- | -- |
|
Dr. Jaroslav Haman Boublik
|
Chief Science Officer & Member of Scientific Advisory Board | 344.77k | -- | -- |
|
Mr. George Lazarou ACA, BCom
|
Company Secretary | -- | -- | -- |
Biome Australia Limited
192-194 Johnston Street
Collingwood, VIC 3066
Australia
- Sector:
- Consumer Defensive
- Industry: Packaged Foods
Description
Biome Australia Limited engages in the development, commercialization, and marketing of live biotherapeutics and complementary medicines in Australia and internationally. It provides its products under the Activated Probiotics and Activated Therapeutics brand names. The company's products are used to support the management of low mood and sleep, bone health, iron malabsorption, mild eczema, and IBS. It markets its products through community pharmacies, independent health practitioners, and health professionals. The company was incorporated in 2018 and is based in Collingwood, Australia.
Corporate Governance
Biome Australia Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of
Institutional Shareholder Services (ISS)
Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
